BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Cardea Bio Appoints Experienced Health Technology Executive, Dr. Kelly Huang, as Chief Operating Officer

  Cardea Bio, a Tech+Bio company integrating molecular biology with semiconductor electronics, appoints Kelly Huang, Ph.D. as Chief Operating Officer (COO).

  June 22, 2021

   · 

  3 min read
• Deals

  Avania Acquires IMARC, Global Medical Device CRO

  Avania , a leading global medical technology CRO, today announced its acquisition of IMARC, a highly respected medical device CRO headquartered in Strongsville, Ohio and providing service throughout the United States.

  June 22, 2021

   · 

  2 min read
• Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital

  Enveda Biosciences today announced an oversubscribed $51M Series A funding round.

  June 22, 2021

   · 

  3 min read
• Drug Development

  Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

  Xentria Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed that the Company satisfactorily addressed all requirements and can proceed with initiation of the planned Phase 1 clinical trial of XTMAB-16.

  June 22, 2021

   · 

  2 min read
• Business

  Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chief Executive Officer

  Alchemab Therapeutics today announced the appointment of Douglas A. Treco, PhD as Chief Executive Officer.

  June 22, 2021

   · 

  4 min read
• Drug Development

  Imbria Pharmaceuticals Announces Enrolment of the First 10 Patients in IMPROVE-DiCE, an Exploratory Phase 2 Study Investigating the impact of IMB-1018972 on Cardiac Energetics, Metabolism and Function in Patients with Type 2 Diabetes

  Imbria Pharmaceuticals today announced that the first 10 (ten) patients were dosed in the IMPROVE-DiCE Phase 2a, open-label study of IMB-1018972 (IMB-101) in patients with Type 2 diabetes at risk of diabetic cardiomyopathy.

  June 22, 2021

   · 

  3 min read
• Lone Star Bio

  Integrity BioChem’s Latest Innovation Gains Industry Recognition at the 2021 ICIS World Surfactants Conference and Awards

  Integrity BioChem was recognized at the 2021 ICIS World Surfactants Conference and Awards for its new technology EdenSurf, which was shortlisted in both the Newcomer and Innovation award categories.

  June 22, 2021

   · 

  3 min read
• Business

  Caribou Biosciences Appoints Scott Braunstein, M.D. to Board of Directors

  Caribou Biosciences, Inc. announced today that it has appointed Scott Braunstein, M.D. to its board of directors.

  June 22, 2021

   · 

  4 min read
• Bio NC

  THREAD DESIGN Launch Will Maximize Effectiveness of Decentralized Clinical Trials

  THREAD, a technology and service provider enabling decentralized clinical trials (“DCTs”), today announced the launch of a new offering, THREAD DESIGN.

  June 22, 2021

   · 

  2 min read
• Business

  Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021

  Cyanotech Corporation announced financial results for the fourth quarter and fiscal year 2021, ended March 31, 2021.

  June 22, 2021

   · 

  7 min read